Found: 5
Select item for more details and to access through your institution.
Evaluation of the Pharmacokinetic Drug Interaction of Capmatinib With Itraconazole and Rifampicin and Potential Impact on Renal Transporters in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 2, p. 228, doi. 10.1002/jcph.2153
- By:
- Publication type:
- Article
Effect of capmatinib on the pharmacokinetics of substrates of CYP3A (midazolam) and CYP1A2 (caffeine) in patients with MET‐dysregulated solid tumours.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 3, p. 1046, doi. 10.1111/bcp.15544
- By:
- Publication type:
- Article
Pharmacokinetics of capmatinib in participants with hepatic impairment: A phase 1, open‐label, single‐dose, parallel‐group study.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 91, doi. 10.1111/bcp.14929
- By:
- Publication type:
- Article
Effect of capmatinib on the pharmacokinetics of digoxin and rosuvastatin administered as a 2‐drug cocktail in patients with MET‐dysregulated advanced solid tumours: A phase I, multicentre, open‐label, single‐sequence drug–drug interaction study
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 7, p. 2867, doi. 10.1111/bcp.14697
- By:
- Publication type:
- Article
Midostaurin drug interaction profile: a comprehensive assessment of CYP3A, CYP2B6, and CYP2C8 drug substrates, and oral contraceptives in healthy participants.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 5, p. 439, doi. 10.1007/s00280-023-04635-3
- By:
- Publication type:
- Article